The ASG Group is pleased to announce it has added a registered mortgage brokerage to its family of investment services. Call us about new offerings.
With great success, ASG continues offering investments in branded hotels across Canada. Our partner, Pacrim Hospitality has extended its business model to include Holloway Hospitality REIT. This has many advantages for ASG investors.
Private Equity and Corporate Finance
ASG Financial Corp. provides practical financing solutions and financial and advisory services specifically designed to meet our clients' objectives. Our team draws on its extensive experience to provide a range of services that are typically not available through traditional brokerage or investment banking firms. We are focused on assisting growth oriented companies meet their strategic objectives.
ASG's team has extensive experience in financial restructuring as well as access to institutional, corporate and private equity sources of capital. ASG together with our international affiliates assist our clients by broadening their capital base, or facilitating strategic alliances, mergers or acquisitions. Our ability to provide customized services in diverse international markets whilst working together as an international team differentiates us from larger organizations with more rigid corporate structures. We analyze alternatives and work closely with our clients to identify the optimal solution and assist in negotiating terms that will enable them to maximize their potential.
ASG and its affiliates have extensive contacts within the international investment community as well as corporate entities interested in participating with dynamic growth-oriented entrepreneurial companies. We understand their interests and priorities and provide them with access to innovative, emerging opportunities.
ASG covers a broad range of sectors including life-sciences, financial services and enabling technologies. We have a consistent flow of opportunities that have been screened and selected based on the viability of the business model and managements' ability to execute the company's plans.
Selected Completed Private Equity Transactions
In January 2001 we completed the first institutional round of financing of US$12million for a US bio-medical technology company. The round was led by a major international fund together with a leading North American pharmaceutical company.
In March 2001 we completed a CDN$3.25million private placement for a Canadian publicly listed resource company. The placement was fully subscribed for by a Swiss financial investment group.
In June 2001 we introduced a major international real estate company to a Canadian real estate developer and assisted in the negotiations for the purchase of 65 condominium units by the international company.
During late 2002 and the first part of 2003 we completed follow-up financing totaling US$4million, for the US bio-medical technology company referred to above, from existing investors.
In July 2003 we completed a $4million Series A financing for an international medical technology company together with our European associates and assisted in establishing a sales and marketing office and clinical trial base in Europe.
In a transaction that closed in 2003, we negotiated the management buy-out of the majority shareholder in a leading Canadian luxury goods manufacturer in a transaction valued at $15million.
During 2003 we introduced a major US bio-technology fund to a leading European publicly quoted pharmaceutical company for co-development, licensing and distribution of molecules and other pharmaceutical products.
In late 2003, we were mandated by a major Canadian public company to identify and introduce a specialist advisory and financial structuring entity to perform a strategic review of the corporation’s operations and financing structure leading to the development and implementation of a strategic plan and capital restructuring. In February 2005 a refinancing of $75million was completed. We acted as joint advisors to the transaction.
From March 2002 until September 2004 we acted as exclusive financial advisors to a US based medical device company.
In July 2005 we were mandated by a leading Ontario real estate developer to introduce an equity partner to participate in the development of a condominium project in southern Ontario. We identified a qualified overseas developer seeking to establish a presence in North America. The transaction closed in October 2005. Equity introduced was $5.7million.
In November 2005 we raised a bridge loan for a technology company based in Ottawa, Ontario to finance production of its patented device.
In November 2005 we raised a bridge loan for a Toronto based healthcare company to facilitate the opening of its second location.
In December 2005 we raised in excess of $1.6million of equity for a Canadian financial services company to finance the roll-out of its new process.
